Johnson & Johnson (BCBA:JNJ)

Market Cap	559.10T
Revenue (ttm)	107.61T
Net Income (ttm)	26.91T
Shares Out	n/a
EPS (ttm)	11,083.28
PE Ratio	20.78
Forward PE	16.36
Dividend	226.09 (1.45%)
Ex-Dividend Date	May 27, 2025

Volume	10,210
Average Volume	11,678
Open	15,625
Previous Close	15,400
Day's Range	15,500 - 15,675
52-Week Range	10,425 - 15,675
Beta	0.40
RSI	73.79
Earnings Date	Oct 14, 2025

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizo...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1886
• Employees: 138,100
• Stock Exchange: Buenos Aires Stock Exchange
• Ticker Symbol: JNJ

Financial Performance

In 2024, Johnson & Johnson's revenue was $88.82 billion, an increase of 4.30% compared to the previous year's $85.16 billion. Earnings were $14.07 billion, a decrease of -59.99%.

Financial numbers in USD